Search Results

A cross‐sectional study of α‐synuclein seed amplification assay in Alzheimer's disease neuroimaging initiative: Prevalence and associations with Alzheimer's disease biomarkers and cognitive function.

• Authors : Tosun, Duygu; Hausle, Zachary; Iwaki, Hirotaka

• Source: Alzheimer's & Dementia: The Journal of the Alzheimer's Association; Aug2024, Vol. 20 Issue 8, p5114-5131, 18p

Record details

Medial temporal lobe gray matter microstructure in preclinical Alzheimer's disease.

• Authors : Brown, Christopher; Das, Sandhitsu; Xie, Long

• Source: Alzheimer's & Dementia: The Journal of the Alzheimer's Association; Jun2024, Vol. 20 Issue 6, p4147-4158, 12p

Record details

Pathologic and cognitive correlates of plasma biomarkers in neurodegenerative disease.

• Authors : Cousins, Katheryn A. Q.; Phillips, Jeffrey S.; Das, Sandhitsu R.

• Source: Alzheimer's & Dementia: The Journal of the Alzheimer's Association; Jun2024, Vol. 20 Issue 6, p3889-3905, 17p

Record details

Relationships of Cognitive Measures with Cerebrospinal Fluid but Not Imaging Biomarkers of Alzheimer Disease Vary between Black and White Individuals.

• Authors : Bonomi, Samuele; Lu, Ruijin; Schindler, Suzanne E.

Subjects: BLACK people; CEREBROSPINAL fluid; ALZHEIMER'S disease

• Source: Annals of Neurology; Mar2024, Vol. 95 Issue 3, p495-506, 12p

Record details

The Alzheimer's Disease Neuroimaging Initiative in the era of Alzheimer's disease treatment: A review of ADNI studies from 2021 to 2022.

• Authors : Veitch, Dallas P.; Weiner, Michael W.; Miller, Melanie

• Source: Alzheimer's & Dementia: The Journal of the Alzheimer's Association; Jan2024, Vol. 20 Issue 1, p652-694, 43p

Record details

Plasma glial fibrillary acidic protein is associated with concomitant brain β‐amyloid in Lewy body disease.

• Authors : Cousins, Katheryn A Q; Irwin, David J.; Chen‐Plotkin, Alice

• Source: Alzheimer's & Dementia: The Journal of the Alzheimer's Association; Dec2023 Supplement 15, Vol. 19, p1-4, 4p

Record details

Neuropathology‐based APOE genetic risk score better quantifies Alzheimer's risk.

• Authors : Deming, Yuetiva; Vasiljevic, Eva; Morrow, Autumn

• Source: Alzheimer's & Dementia: The Journal of the Alzheimer's Association; Aug2023, Vol. 19 Issue 8, p3406-3416, 11p

Record details

Burden of cerebral small vessel disease modifies relationship between some plasma Abeta 42/40 assays, but not p‐tau181 assays, with amyloid PET.

• Authors : Lesman‐Segev, Orit H.; La Joie, Renaud; Rozen, Yael

• Source: Alzheimer's & Dementia: The Journal of the Alzheimer's Association; Dec2023 Supplement 14, Vol. 19, p1-3, 3p

Record details

Plasma GFAP associates with secondary Alzheimer's pathology in Lewy body disease.

• Authors : Cousins, Katheryn A. Q.; Irwin, David J.; Chen‐Plotkin, Alice

Subjects: ALZHEIMER'S disease; GLIAL fibrillary acidic protein

• Source: Annals of Clinical & Translational Neurology; May2023, Vol. 10 Issue 5, p802-813, 12p

Record details

Cerebrospinal fluid biomarker panel of synaptic dysfunction in Alzheimer's disease and other neurodegenerative disorders.

• Authors : Nilsson, Johanna; Cousins, Katheryn A.Q.; Gobom, Johan

• Source: Alzheimer's & Dementia: The Journal of the Alzheimer's Association; May2023, Vol. 19 Issue 5, p1775-1784, 10p

Record details